Fig. 2From: Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trialThe dose conversion of animal study for RCT: The human equivalent dose was 24.3Â mg/kg which for a 60-kg person was about 1500Â mg/dayBack to article page